NEW YORK (GenomeWeb News) – Tm Bioscience today reported that net losses for the second quarter increased despite a 55-percent surge in revenues.
 
The company reported $3 million in revenues for the quarter ended June 30, up from $2 million during the same quarter a year ago.
 
Product sales for the second quarterclimbed 80 percent to $2.9 million from $1.6 million in second quarter 2005, the company said. It added that sales of Tag-It CF70 reagents and increased demand from Genzyme drove the growth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.